Cargando…
Characterizing the Genomic Landscape of Brain Glioma With Circulating Tumor DNA From Tumor In Situ Fluid
Tumor in situ fluid (TISF) refers to the fluid at the local surgical cavity. We evaluated the feasibility of TISF-derived circulating tumor DNA (ctDNA) characterizing the genomic landscape for glioma. This retrospective study included TISF and tumor samples from 10 patients with glioma, we extracted...
Autores principales: | Sheng, Zhiyuan, Yu, Jinliang, Deng, Kaiyuan, Andrade-Barazarte, Hugo, Zemmar, Ajmal, Li, Sijia, Li, Nianxuan, Yan, Zhaoyue, Chen, Zhongcan, Sun, Yong, Hernesniemi, Juha, Bu, Xingyao |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8045748/ https://www.ncbi.nlm.nih.gov/pubmed/33868989 http://dx.doi.org/10.3389/fonc.2021.584988 |
Ejemplares similares
-
Tumor DNA From Tumor In Situ Fluid Reveals Mutation Landscape of Minimal Residual Disease After Glioma Surgery and Risk of Early Recurrence
por: Yu, Jinliang, et al.
Publicado: (2021) -
Tracking tumor evolution during the first-line treatment in brain glioma via serial profiling of cell-free tumor DNA from tumor in situ fluid
por: Sheng, Zhiyuan, et al.
Publicado: (2023) -
Constrained-Spherical Deconvolution Tractography in the Evaluation of the Corticospinal Tract in Glioma Surgery
por: Sheng, Zhiyuan, et al.
Publicado: (2021) -
Integrating real‐time in vivo tumour genomes for longitudinal analysis and management of glioma recurrence
por: Sheng, Zhiyuan, et al.
Publicado: (2021) -
Real‐time longitudinal analysis of human gliomas reveals in vivo genome evolution and therapeutic impact under standardized treatment
por: Xu, Sensen, et al.
Publicado: (2022)